Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


1 Ann Neurol
2 BMC Neurol
1 J Neurochem
2 Mov Disord
1 Nat Rev Neurol
1 Neurology
4 Neurosci Lett
1 Neuroscience
1 Proc Natl Acad Sci U S A
3 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. DARVISH H, Azcona LJ, Taghavi S, Firouzabadi SG, et al
    ANXA1 with anti-inflammatory properties might contribute to parkinsonism.
    Ann Neurol. 2021 Jun 28. doi: 10.1002/ana.26148.
    PubMed         Abstract available

    BMC Neurol

  2. LIEBERT A, Bicknell B, Laakso EL, Heller G, et al
    Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study.
    BMC Neurol. 2021;21:256.
    PubMed         Abstract available

  3. PHAM NGUYEN TP, Abraham DS, Thibault D, Weintraub D, et al
    Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?
    BMC Neurol. 2021;21:240.
    PubMed         Abstract available

    J Neurochem

  4. MASATO A, Bubacco L, Greggio E
    Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metaboli
    J Neurochem. 2021 Jun 28. doi: 10.1111/jnc.15442.
    PubMed         Abstract available

    Mov Disord

  5. VIDENOVIC A, Amara AW, Comella C, Schweitzer PK, et al
    Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.
    Mov Disord. 2021 Jun 30. doi: 10.1002/mds.28702.
    PubMed         Abstract available

  6. CHOONG CJ, Kimura Y, Mochizuki H
    Disturbed Mitochondria-Lysosome Crosstalk in GBA1-Associated Parkinson's Disease.
    Mov Disord. 2021 Jul 1. doi: 10.1002/mds.28693.

    Nat Rev Neurol

  7. WOOD H
    A new scale to assess gastrointestinal dysfunction in Parkinson disease.
    Nat Rev Neurol. 2021 Jun 29. pii: 10.1038/s41582-021-00534.


  8. PRASUHN J, Prasuhn M, Fellbrich A, Strautz R, et al
    Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
    Neurology. 2021 Jun 29. pii: WNL.0000000000012444.
    PubMed         Abstract available

    Neurosci Lett

  9. YIN K, Zhou C, Yin L, Zhu Y, et al
    Resting-state functional magnetic resonance imaging of the cerebellar vermis in patients with Parkinson's disease and visuospatial disorder.
    Neurosci Lett. 2021;760:136082.
    PubMed         Abstract available

  10. SUN D, Wu X, Xia Y, Wu F, et al
    Differentiating Parkinson's Disease Motor Subtypes: A Radiomics Analysis Based on Deep Gray Nuclear Lesion and White Matter.
    Neurosci Lett. 2021 Jun 23:136083. doi: 10.1016/j.neulet.2021.136083.
    PubMed         Abstract available

  11. DA SILVA WAB, Ferreira Oliveira K, Caroline Vitorino L, Ferreira Romao L, et al
    Physical exercise increases the production of tyrosine hydroxylase and CDNF in the spinal cord of a Parkinson's disease mouse model.
    Neurosci Lett. 2021 Jun 25:136089. doi: 10.1016/j.neulet.2021.136089.
    PubMed         Abstract available

  12. BAI X, Dong Q, Zhao L, Yao Y, et al
    microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease.
    Neurosci Lett. 2021 Jun 30:136094. doi: 10.1016/j.neulet.2021.136094.
    PubMed         Abstract available


  13. ZHENG H, Xie Z, Zhang X, Mao J, et al
    Investigation of alpha-synuclein species in plasma exosomes and the oligomeric and phosphorylated alpha-synuclein as potential peripheral biomarker of Parkinson's Disease.
    Neuroscience. 2021 Jun 26. pii: S0306-4522(21)00331.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  14. ZHANG S, Liu YQ, Jia C, Lim YJ, et al
    Mechanistic basis for receptor-mediated pathological alpha-synuclein fibril cell-to-cell transmission in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    Rev Neurol (Paris)

  15. FENELON G, Walusinski O
    The landmark contributions of Paul Blocq, Georges Marinesco, and Edouard Brissaud in Parkinson's disease.
    Rev Neurol (Paris). 2021 Jun 26. pii: S0035-3787(21)00576.
    PubMed         Abstract available

  16. DEROLLEZ C, Carriere N, Kyheng M, Dujardin K, et al
    Factors that predict a change in quality of life among Parkinson's disease patients participating in a patient education program.
    Rev Neurol (Paris). 2021 Jun 25. pii: S0035-3787(21)00574.
    PubMed         Abstract available

    Mini review - The role of Glucocerebrosidase and Progranulin as possible targets in the treatment of Parkinson's disease.
    Rev Neurol (Paris). 2021 Jun 23. pii: S0035-3787(21)00567.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.